FDA Inspection
Michelle Sato, M.D.Michelle Sato, M.D. – FDA Inspection, Aug 13, 2021
Record Details
This FDA Inspection record concerns Michelle Sato, M.D., with an inspection on August 13, 2021, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Michelle Sato, M.D.
- Inspection Date
- August 13, 2021
- Product Type
- Drugs
View Company Profile
ID · 0e790bfe-c531-488c-bd04-f0dbbe71b7a0
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1149553
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
1- 21 CFR 312.60FD-1572, protocol compliance
Full citation text and observation details available on the Dashboard.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.